Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial-Reference-Cited by-同舟云学术

Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial

Published:2017-03-07 Issue:1 Volume:18 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Gopaluni Seerapani, ,Smith Rona M.,Lewin Michelle,McAlear Carol A.,Mynard Kim,Jones Rachel B.,Specks Ulrich,Merkel Peter A.,Jayne David R. W.

Funder

Arthritis Research UK

National Institute for Arthritis and Musculoskeletal and Skin Diseases

National Center for Advancing Translational Sciences

F. Hoffmann-La Roche

Japanese Ministry of Health, Labour and Welfare

Genentech

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13063-017-1857-z.pdf

Reference19 articles.

1. Watts RA, Gonzalez-Gay MA, Lane SE, Garcia-Porrua C, Bentham G, Scott DG. Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe. Ann Rheum Dis. 2001;60(2):170–2.

2. Frohnert PP, Sheps SG. Long-term follow-up study of periarteritis nodosa. Am J Med. 1967;43(1):8–14.

3. de Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross WL, et al. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med. 2009;150(10):670–80.

4. Wegener’s Granulomatosis Etanercept Trial Research Group. Etanercept plus standard therapy for Wegener’s granulomatosis. N Engl J Med. 2005;352(4):351–61.

5. Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349(1):36–44.

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on risk factors for relapse in antineutrophil cytoplasmic antibody-associated vasculitis;Clinical and Experimental Immunology;2024-08-14

2. Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis;Frontiers in Pharmacology;2024-05-20

3. Headaches and Vasculitis;Neurologic Clinics;2024-05

4. Anti-CD20 antibodies in glomerular diseases, their resistance and reversal approaches;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

5. Systemic vasculitis and headache;Current Opinion in Neurology;2023-10-12